51 filings
Page 2 of 3
8-K
skxt bczaxb9jvs43
30 Oct 23
Regulation FD Disclosure
8:05am
8-K
kxd 1e7aqwsj1
24 Oct 23
Other Events
8:05am
8-K/A
fqv3ts3rci
19 Oct 23
Financial Statements and Exhibits
5:23pm
8-K
d4abf3z5ra4xwttaf
5 Oct 23
Index to Financial Statements
5:12pm
8-K
cf1ed46dqb57o0ut
29 Sep 23
Entry into a Material Definitive Agreement
5:24pm
8-K
4dct8xh0w padf
29 Sep 23
Submission of Matters to a Vote of Security Holders
3:11pm
8-K
67mfh25l6slr w56mk
22 Sep 23
Entry into a Material Definitive Agreement
12:55pm
8-K
62ghkv209xl 633
22 Sep 23
Graf Acquisition Corp. IV Announces Adjournment of Special Meeting
9:26am
8-K
0bixehue
19 Sep 23
Entry into a Material Definitive Agreement
3:51pm
8-K
tbher49l
18 Sep 23
Entry into a Material Definitive Agreement
9:25am
8-K
osm xc57c
14 Sep 23
Graf Acquisition Corp. IV Announces Adjournment of Special Meeting
9:30am
8-K
d3719 yws
11 Sep 23
Graf Acquisition Corp. IV Announces Adjournment of Special Meeting
11:30am
8-K
hwbmaasb 67xovk65e
30 Aug 23
Graf Acquisition Corp. IV Announces Intent to Adjourn Special Meeting
7:30am
8-K
jsw q29nb8x
15 Aug 23
Graf Acquisition Corp. Iv and Nkgen Biotech, Inc. Announce Effectiveness of Form S-4 for Proposed Business Combination
4:30pm
8-K
rbwc8cl7isdciz x36th
26 Jul 23
For Investor Use Only For Investor Use Only Maximizing Immune Integrity Investor Event Presentation July 2023
11:54am
8-K
at85drujhv3 fv3u6
17 Jul 23
NKGen Biotech Presents Interim Phase I Trial Data at 2023 Alzheimer’s Association International Conference
8:00am
8-K
jys36g63f1x6g ua7ai
5 Jun 23
Regulation FD Disclosure
8:30am
8-K
rt1m0gmy2ffvyam wdf
31 May 23
Confidential Confidential Maximizing Immune Integrity Corporate Presentation May 2023
9:45pm
8-K
pz6zj
22 May 23
Amendments to Articles of Incorporation or Bylaws
9:03pm
8-K
q3hf0qkmj7
17 Apr 23
Entry into a Material Definitive Agreement
6:01am